Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating initiation and titration of insulin glargine (U300) in insulin-naïve patients with type 2 diabetes controlled on oral agents in Turkey;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine U300 (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED